Evidence map›Paper›PMID 30104212›Full record

ArticleInfection and immunity2018

Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.

Rajesh Mani, Manish Gupta, Anshu Malik, Ravi Tandon, Rajendra Prasad, Rakesh Bhatnagar, Nirupama Banerjee

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecular therapy oncolytics · 2021
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rajesh Mani *Molecular and Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Manish Gupta *Molecular and Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Anshu MalikMolecular and Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Ravi TandonLaboratory of AIDS Research and Immunology, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Rajendra PrasadAmity Institute of Biotechnology, Amity University, Amity Education Valley, Gurgaon, Haryana, India.
Rakesh BhatnagarMolecular and Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Nirupama BanerjeeMolecular and Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India nirupamaban@yahoo.com.
Jawaharlal Nehru University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel adjuvants are in demand for improving the efficacy of human vaccines. The immunomodulatory properties of

Indexed as

AcyltransferasesAdjuvants, ImmunologicAnimalsAntibodies, BacterialAntigens, BacterialBacterial ProteinsCell WallFemaleFreund's AdjuvantHumansInterleukin-17Interleukin-2MiceMice, Inbred C57BLMycobacterium tuberculosisPeptidesAcyltransferasesAdjuvants, ImmunologicAntibodies, Bacterialantigen 85B, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsESAT-6 protein, Mycobacterium tuberculosisFreund's AdjuvantInterleukin-17Interleukin-2PeptidespolyglutamineTuberculosis Vaccinesadjuvantscell wallESAT-6Mycobacterium tuberculosis H37Rvpoly-α-l-glutamineTh1/Th2/Th17 responsesvaccines

Identifiers

PMID30104212
PMCPMC6204737
OpenAlexW2887545761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.